NCT05663593View on ClinicalTrials.gov

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 23, 2022

Primary Completion Date

August 15, 2022

Study Completion Date

November 30, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

HSK31858, tablet

Starting dose in single ascending dose: 5 mg

DRUG

Placebo, tablet

Matching placebo

Trial Locations (1)

255400

PKUCare Luzhong Hospital, Zibo

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY